in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Peregrine Pharmaceuticals, Seaside Therapeutics and Eucodis.
Do you enjoy reading our latest headlines? Then, why not help to write them yourself by working as a freelance correspondent for Outsourcing-Pharma.com?
World Courier has opened investigational drug storage facilities in South Africa and Australia, a move it says is in response to growth in the regions' clinical trials markets.
SAFC Pharma has added extra viral and biologics capacity at its California plant in a $12m project that allows it to take projects from the lab to commercial scale.
Melbourn Scientific has expanded its portfolio by adding terahertz imaging, which is "the next stage" in non-destructive film thickness evaluation technology, the company's CEO told Outsourcing-Pharma.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including elections to ISPE's board and a Roche exec joining Dendreon's board.
Novartis has optioned rights to apply Heptares Therapeutics’ Star GPCR technology to one of its drug development programmes in a deal that, the UK firm says, could be worth over $200m.
We look ahead to CPhI 2009 which takes place in Madrid, Spain next week and will showcase the world’s leading ingredients, contract services, machinery and biotech companies.
GlaxoSmithKline (GSK) and other pharmas concerned by parallel trade have been given encouragement by Europe’s highest court which said the EC must reconsider the company’s Spanish sale conditions.
Symphony Metro Pharma Solutions and HP Solutions have created a new application that, they claim, can help drug marketeers identify activities with the greatest revenue potential.
DHL is investing $15m (€10.2m) in its logistics infrastructure in Asia, increasing capacity in India to meet demand for supply chain services that are in compliance with stricter regulatory and quality requirements.
MannKind’s share price tumbled by 31 per cent yesterday, just days after it published encouraging safety data for Afresa, because it revealed a partnership deal is unlikely to occur in 2009.
Despite the government’s “aggressive” promotion of generic drugs, pharmaceutical spending in France will continue to grow, according to new analysis by Business Monitor International (BMI).
GSK has won 22 government orders for its H1N1 swine flu vaccine in the past two months, taking total sales to 440m doses which media reports suggest will earn the company £2.2bn ($3.5bn).
Pharma’s reliance on outsourcing and products developed by biotechs could cause the pace of innovation to “decline considerably”, according to experts that are concerned about the lack of funding for small businesses.
in-PharmaTechnologist presents its latest round up of movements in the pharma space, including appointments at Sigma-Aldrich, Novavax and Pfizer’s CEO taking on an additional role.
Sun Pharmaceuticals says the new lawsuit filed against it by Taro Pharmaceuticals is “another unfortunate attempt by the Taro directors to divert Taro's limited resources to assisting the Levitt family in their ongoing refusal to comply with their...
US companies Savvion and Patni Life Sciences hope their new alliance help pharmas biotechs and CROs meet regulatory challenges “across the drug development cycle.”
Axiom Accelerated Patient Recruitment hopes its new range of SMS, text messaging, services can help CROs and pharma sponsors reach more potential study participants.
The FDA is to establish current good manufacturing practice (cGMP) requirements for combination products to eliminate inconsistencies that could affect product safety and public health.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Catalent, MedSource and IGI Laboratories and PHT.
Fierce competition from India and China means it is unlikely that CROs and CMOs in CEE can generate sustainable growth, according to a report that believes the service model must be a “stepping stone” to creating innovative R&D businesses.
in-PharmaTechnologist presents its latest round up of appointments in the pharma sector, including a new president of Eli Lilly USA and a resignation over disagreements at Caraco.
ethica Clinical has added biomarker data analysis technology to its roster of services in a C$1.25m (€782,899) deal with fellow Canadian CRO Matrix Pharma.
GATC Biotech has expanded its human genome sequencing services and, having performed a pilot study, is “amazed” by the potential the techniques have for cancer research and diagnostics.
US approval for Sanofi-Aventis’ H1N1 vaccine last week is an “example of extremely rapid action by [the] FDA” that should be used more widely, according to Parexel Consulting’s VP of global strategy services Alberto Grignolo.
Israeli generics giant Teva Pharmaceutical Industries will close one of its manufacturing plants in the Czech Republic by the end of the year, resulting in the loss of around 400 jobs.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing space, including appointments at IMS Health, CPTC and LAB Research Canada.
in-PharmaTechnologist presents its latest round up of movements in the pharma space, including appointments at Sanofi-Aventis, MorphoSys and Ironwood Pharmaceuticals.
Apotex’s manufacturing difficulties have begun to impact on its operations, with the company recalling some products, New Zealand authorities issuing a temporary import ban and lay offs at a supplier.
Market intelligence giant IMS Health has extended its KPO market and sales analytics offering and signed a new collaboration deal with Indian IT contracting group Tata Consultancy Services (TCS).
US biotechnology major Genzyme has begun $68m of refurbishment work on a new 211,000 sgft manufacturing and shipping complex in Northborough, Massachusetts.
The FDA has approved four H1N1 vaccines, made by CSL, AstraZeneca, Novartis and Sanofi-Aventis, that will be distributed in the next four weeks as part of the US’ swine flu preparation.
Orasi Medical claims CROs and pharmas can cut the cost and length of Alzheimer’s trials, and improve accuracy, by using its brain function measuring service, which is now being promoted in Japan.
US drugmaker Eli Lilly plans to cut 5,500 jobs by 2011 as it prepares to enter what CEO John Lechleiter said will be “the most challenging period in [the] company’s history.”
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Hovione, Agilux, McKesson and CIT.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including Roche appointing Genentech’s CEO to lead its pharma division and Mylan’s CFO leaving after three months in the job.
More than 50 per cent of executives believe their company fails to respond quickly enough to pandemics because of lapses in the supply chain, according to an IBM survey.
Transcrip Partners’ “augmentation” solution for contract R&D “differs from the normal consultancy alternative by fielding ‘doers’ who can think strategically and ‘thinkers’ who are happy to get their hands dirty” according to senior partner Paul Branthwaite.
Phlexglobal’s new contract with UCB will improve how the Belgian drug firm manages trials and is indicative of a wider industry move towards eTMF, according to CEO Nicola Murgatroyd.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Cytovance, MPI Research and UBC.
in-PharmaTechnologist presents its latest round up of movements in the pharma space, including Merck’s post-merger management structure and a difference of opinion at LifeCycle Pharma.
